From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialty Care>
  3. Oncology and Hematology>
  4. Archives

Oncology and Hematology: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

 to   
Items 1-10 of 271 are shown

Risk Factors for Pulmonary Hypertension in Sickle Cell Patients

  • Summary and Comment
  • Subscription required

Genetic variants in SCD patients were associated with PH.

Lenalidomide for Relapsed Chronic Lymphocytic Leukemia Patients

  • Summary and Comment
  • Free

Lenalidomide, given as a continuous daily oral dose, showed antitumor activity in one third of heavily pretreated CLL patients.

Perioperative Thrombosis Prevention in Cancer Patients

  • Summary and Comment
  • Subscription required

Venous thromboembolism was less common with low-molecular-weight heparins versus unfractionated heparin, but survival was unaffected.

Thromboses, Microparticles, and Thrombin Generation: How Are They Linked?

  • Summary and Comment
  • Subscription required

Patients with thrombosis had more microparticle-mediated thrombin generation than did normal controls.

Rivaroxaban for Thromboprophylaxis After Joint Replacement

  • Summary and Comment
  • Free

In two large, randomized studies, rivaroxaban was superior to enoxaparin in preventing venous thrombosis.

Sleep Disturbance and Cancer

  • Summary and Comment
  • Subscription required

Patients with advanced cancer had difficulty maintaining both sleep and waking states.

Reversing Immunopathology with Rituximab in Cryoglobulinemia Patients

  • Summary and Comment
  • Subscription required

B-cell depletion therapy with rituximab could be effective for patients with HCV-related mixed cryoglobulinemia.

Extended Androgen-Deprivation Therapy for Prostate Cancer

  • Summary and Comment
  • Subscription required

Disease-free survival at 10 years was better for patients who received post-radiation ADT than for those who did not.

Salvage Radiotherapy in Radical Prostatectomy Patients with PSA-Only Relapses

  • Summary and Comment
  • Subscription required

Salvage therapy was most beneficial for men who received therapy within 2 years of biochemical failure.

Why Is Warfarin Such a Dangerous Drug?

  • Summary and Comment
  • Free

Many patients who receive warfarin would have been excluded from the trials in which the drug’s efficacy versus safety was assessed.

Items 1-10 of 271 are shown
 to   
Copyright © 2008. Massachusetts Medical Society. All rights reserved.